Gamitrinib TPP hexafluorophosphate - CAS 1131626-47-5

Gamitrinib TPP hexafluorophosphate is a mitochondrial-targeted HSP90 inhibitor with anticancer activity, which can regulate cell cycle and cell homeostasis and can be used to study cancer, neurodegenerative diseases and viral infections.

Antifungal, HSP

Cytoskeletal Signaling, Metabolism, Microbiology/Virology

1131574

0.9852

C52H65F6N3O8P2

1036.03

O=C(C=C1NC(/C(C)=C\C=C\[C@@H]([C@H](/C(C)=C/[C@H](C)[C@H]([C@@H](OC)C[C@@H](C2)C)O)OC(N)=O)OC)=O)C(NCCCCCC[P+](C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5)=C2C1=O.F[P-](F)(F)(F)(F)F

-20°C

Ice Packs

Small Compound